Traders purchased shares of Humana Inc (NYSE:HUM) on weakness during trading on Friday. $96.37 million flowed into the stock on the tick-up and $29.72 million flowed out of the stock on the tick-down, for a money net flow of $66.65 million into the stock. Of all stocks tracked, Humana had the 16th highest net in-flow for the day. Humana traded down ($3.93) for the day and closed at $328.38

Several equities analysts have weighed in on HUM shares. Bank of America lifted their price objective on Humana from $338.00 to $375.00 and gave the company a “buy” rating in a report on Thursday, August 2nd. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $377.00 price objective for the company in a report on Thursday, October 4th. Piper Jaffray Companies lifted their price objective on Humana from $326.00 to $350.00 and gave the company an “overweight” rating in a report on Friday, July 6th. ValuEngine raised Humana from a “hold” rating to a “buy” rating in a report on Wednesday, July 4th. Finally, BMO Capital Markets lifted their price objective on Humana from $328.00 to $355.00 and gave the company an “outperform” rating in a report on Monday, June 25th. Seven analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $339.79.

The company has a quick ratio of 1.43, a current ratio of 1.43 and a debt-to-equity ratio of 0.47. The firm has a market capitalization of $45.24 billion, a P/E ratio of 25.71, a price-to-earnings-growth ratio of 1.64 and a beta of 0.97.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, August 1st. The insurance provider reported $3.96 EPS for the quarter, topping analysts’ consensus estimates of $3.79 by $0.17. Humana had a return on equity of 17.43% and a net margin of 2.48%. The company had revenue of $14.26 billion during the quarter, compared to analysts’ expectations of $14.16 billion. During the same quarter in the previous year, the firm earned $3.49 EPS. On average, equities research analysts anticipate that Humana Inc will post 14.18 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 26th. Stockholders of record on Friday, September 28th will be issued a dividend of $0.50 per share. The ex-dividend date is Thursday, September 27th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.61%. Humana’s dividend payout ratio (DPR) is currently 17.08%.

In other news, CEO Bruce D. Broussard sold 18,000 shares of the business’s stock in a transaction on Monday, September 10th. The stock was sold at an average price of $328.66, for a total transaction of $5,915,880.00. Following the completion of the transaction, the chief executive officer now owns 71,085 shares of the company’s stock, valued at approximately $23,362,796.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Elizabeth D. Bierbower sold 3,092 shares of the business’s stock in a transaction on Thursday, August 16th. The stock was sold at an average price of $330.00, for a total value of $1,020,360.00. Following the transaction, the insider now directly owns 14,289 shares of the company’s stock, valued at approximately $4,715,370. The disclosure for this sale can be found here. Insiders have sold a total of 40,284 shares of company stock valued at $13,147,715 in the last three months. 0.60% of the stock is owned by insiders.

A number of hedge funds have recently modified their holdings of the stock. FMR LLC grew its position in Humana by 12.7% during the 2nd quarter. FMR LLC now owns 12,212,514 shares of the insurance provider’s stock worth $3,634,811,000 after acquiring an additional 1,374,030 shares during the last quarter. Northern Trust Corp grew its position in Humana by 1.2% during the 2nd quarter. Northern Trust Corp now owns 1,687,211 shares of the insurance provider’s stock worth $502,164,000 after acquiring an additional 20,480 shares during the last quarter. Acadian Asset Management LLC grew its position in Humana by 7.6% during the 2nd quarter. Acadian Asset Management LLC now owns 1,324,681 shares of the insurance provider’s stock worth $394,262,000 after acquiring an additional 93,021 shares during the last quarter. Massachusetts Financial Services Co. MA grew its position in Humana by 3.5% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 768,245 shares of the insurance provider’s stock worth $228,653,000 after acquiring an additional 26,303 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. grew its position in Humana by 1.1% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 582,738 shares of the insurance provider’s stock worth $173,441,000 after acquiring an additional 6,522 shares during the last quarter. Institutional investors and hedge funds own 92.84% of the company’s stock.

Humana Company Profile (NYSE:HUM)

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Recommended Story: What is a Leveraged Buyout (LBO)?

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.